We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$23.7B
AUM Growth
+$1.26B
Cap. Flow
+$2.43B
Cap. Flow %
10.25%
Top 10 Hldgs %
31.04%
Holding
1,328
New
56
Increased
716
Reduced
259
Closed
49

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$229M
2
MSFT icon
Microsoft
MSFT
+$208M
3
NVDA icon
NVIDIA
NVDA
+$198M
4
AMZN icon
Amazon
AMZN
+$197M
5
NOW icon
ServiceNow
NOW
+$193M

Top Sells

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$173M
2
SPG icon
Simon Property Group
SPG
+$154M
3
WELL icon
Welltower
WELL
+$114M
4
AMT icon
American Tower
AMT
+$96.9M
5
ELS icon
Equity Lifestyle Properties
ELS
+$88M

Sector Composition

Rank Sector Weight
1 Real Estate 35.46%
2 Technology 23.73%
3 Communication Services 9.02%
4 Consumer Discretionary 6.33%
5 Financials 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COHR icon
1076
Coherent
COHR
$43.4B
$13K ﹤0.01%
200
-500
-71% -$41.4K
PTCT icon
1077
PTC Therapeutics
PTCT
$6.18B
$13K ﹤0.01%
255
– –
ACLX
1078
DELISTED
Arcellx
ACLX
$12K ﹤0.01%
178
– –
AMRN
1079
Amarin Corp
AMRN
$297M
$12K ﹤0.01%
67
– –
IEI icon
1080
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
$12K ﹤0.01%
102
-20
-16% -$2.33K
AKRO
1081
DELISTED
Akero Therapeutics
AKRO
$11K ﹤0.01%
272
+10
+4% +$424
RARE icon
1082
Ultragenyx Pharmaceutical
RARE
$2.46B
$11K ﹤0.01%
305
– –
RYTM icon
1083
Rhythm Pharmaceuticals
RYTM
$7.31B
$11K ﹤0.01%
203
– –
SWTX
1084
DELISTED
SpringWorks Therapeutics
SWTX
$11K ﹤0.01%
245
– –
ALVO icon
1085
Alvotech
ALVO
$1.19B
$10K ﹤0.01%
1,030
+149
+17% +$1.81K
CRNX icon
1086
Crinetics Pharmaceuticals
CRNX
$8.88B
$10K ﹤0.01%
304
– –
CRSP icon
1087
CRISPR Therapeutics
CRSP
$4.69B
$10K ﹤0.01%
282
– –
IMVT icon
1088
Immunovant
IMVT
$7.93B
$10K ﹤0.01%
581
+97
+20% +$2.03K
MRUS
1089
DELISTED
Merus
MRUS
$10K ﹤0.01%
246
-5
-2% -$218
PTGX icon
1090
Protagonist Therapeutics
PTGX
$8.55B
$10K ﹤0.01%
215
– –
SRRK icon
1091
Scholar Rock
SRRK
$5.88B
$10K ﹤0.01%
309
– –
ACAD icon
1092
Acadia Pharmaceuticals
ACAD
$4.51B
$9K ﹤0.01%
549
– –
AMRX icon
1093
Amneal Pharmaceuticals
AMRX
$6.1B
$9K ﹤0.01%
1,023
– –
APLS
1094
DELISTED
Apellis Pharmaceuticals
APLS
$9K ﹤0.01%
429
-18
-4% -$497
EWTX icon
1095
Edgewise Therapeutics
EWTX
$4.28B
$8K ﹤0.01%
344
– –
FOLD
1096
DELISTED
Amicus Therapeutics
FOLD
$8K ﹤0.01%
986
– –
IBRX icon
1097
ImmunityBio
IBRX
$7.15B
$8K ﹤0.01%
2,620
– –
NAMS icon
1098
NewAmsterdam Pharma
NAMS
$3.26B
$8K ﹤0.01%
375
+70
+23% +$1.56K
TWST icon
1099
Twist Bioscience
TWST
$5.32B
$8K ﹤0.01%
210
– –
VCYT icon
1100
Veracyte
VCYT
$4.45B
$8K ﹤0.01%
266
– –
42 43
44
45 46

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2025 Portfolio in Review

As of Q1 2025, Daiwa Securities Group held 1,328 positions worth $23.7B, up 5.6% from $22.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Daiwa Securities Group deployed $2.43B of net new capital in Q1 2025, opening 56 new positions and adding to 716 existing holdings. Its largest new stake was Autoliv: 89,727 shares worth $7.94M.

By sector, the portfolio is most concentrated in Real Estate at 35% of assets, down from 38% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was VICI Properties, an estimated $173M trimmed.

  • Daiwa Securities Group's largest Q1 2025 buy was Autoliv: 89,727 shares worth $7.94M.
  • Daiwa Securities Group added most to Apple in Q1 2025, an estimated $229M increase.
  • Daiwa Securities Group's biggest Q1 2025 reduction was VICI Properties, cutting an estimated $173M.
  • Daiwa Securities Group fully exited Global X SuperDividend REIT ETF in Q1 2025, selling an estimated $20.8M.
  • Daiwa Securities Group's ten largest holdings make up 31% of its $23.7B portfolio in Q1 2025.
  • Daiwa Securities Group opened 56 new positions and closed 49 in Q1 2025.
  • Daiwa Securities Group's portfolio value rose 5.6% quarter-over-quarter to $23.7B.

Based on Daiwa Securities Group's 13F filing for Q1 2025, filed 13 May 2025.